Anti-Therapeutic Action: diagnostic delays

Knowledge framework and emerging trends of invasive pulmonary fungal infection: A bibliometric analysis (2003–2023)

mycolabadmin

This study examined 20 years of scientific research on invasive lung fungal infections using bibliometric analysis. The research found that the United States leads in fungal infection research, with emerging focus areas including COVID-19-associated fungal infections and new diagnostic methods like metagenomic sequencing. The findings show that diagnosis remains challenging and requires improved detection methods, while treatment typically involves antifungal medications like voriconazole and amphotericin-B.

Read More »

Shared Vision for Improving Outcomes for Serious Fungal Diseases: Report of a Patient, Caregiver, and Clinician Summit

mycolabadmin

Patients with serious fungal infections face significant challenges including long delays before diagnosis, substantial emotional and financial burden, and lasting effects on quality of life. A summit brought together patients, their caregivers, and fungal disease experts to share experiences and identify priorities for improving care. The group identified needs for better diagnostic tools, new treatments, improved medical education about fungal diseases, and patient support programs to help future patients and their families navigate fungal infections more effectively.

Read More »
Scroll to Top